Advanced Research Projects Agency for Health (ARPA-H)
Advanced Research Projects Agency for Health (ARPA-H)
Explore linked clinical trials.9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-10-02 | NCT06577636 | |
| Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-09-18 | NCT07340541 | |
| ARPA-H Smart Band-Aid to Measure Chronic Pain in Women | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not stated | 2026-09-14 | NCT06994988 | |
| Psilocybin-Assisted Therapy for Physician Well-Being and Burnout | Burnout; Burnout, Healthcare Workers | Recruiting | Phase 1 / Phase 2 | 2026-09-02 | NCT06814522 | |
| Study of LNP.UCD.ABE in Patients With Urea Cycle Disorders | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, urea cycle disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-26 | NCT07667387 | |
| A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) | High-risk Human Papillomavirus Infection; Human Papilloma Virus (HPV) | Recruiting | Phase 2 | 2026-08-25 | NCT07601074 | |
| The RECAP2 Study: Midazolam and Psilocybin | Psilocybin | Recruiting | Phase 1 | 2026-08-13 | NCT06692192 | |
| The ENHANCE Study: taVNS and Psilocybin | Healthy; Psychedelic Experiences; Vagus Nerve Stimulation | Recruiting | Phase 1 | 2026-07-29 | NCT05866471 | |
| HAIQU (Hospital AIr QUality) | Acute Respiratory Tract Infection | Not yet recruiting | Not applicable | 2026-06-29 | NCT07670117 |